Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study
January 07, 2025 06:00 ET
|
Biodesix, Inc.
LOUISVILLE, Colo., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced a new post-market clinical...
Agile Manufacturing, Inc. of Beaverton, Ontario, Canada adds a ninth large format 3D Systems Stereolithography (SLA) 3D printer running Accura® Xtreme White 200 material
January 07, 2025 06:00 ET
|
Agile Manufacturing Inc.
Agile Manufacturing Inc. is one of North America's largest privately held 3D Printing Service Bureaus, celebrating their 20th year
Blue Star Families Celebrates Landmark Quality-of-Life Gains for Military Families in 2025 NDAA
January 07, 2025 06:00 ET
|
Blue Star Families
Washington, D.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Blue Star Families, the nation's largest and fastest-growing military-connected organization, marks the inclusion of essential quality-of-life...
Plastic Product & Packaging Manufacturing Market to Surge with 4.7% CAGR, Projected to Hit US$ 1,146.18 Billion by 2034 | Fact.MR Report
January 07, 2025 06:00 ET
|
FACT.MR
Rockville, MD , Jan. 07, 2025 (GLOBE NEWSWIRE) -- Based on the newly published report by Fact.MR, a market research and competitive intelligence provider, the global Plastic Product & Packaging...
Despite Interest Rate Cuts, More Than 1 in 4 Canadians Expect to be Unable to Pay Bills – Yet More Than 1 in 5 Plan to Take on More Debt
January 07, 2025 06:00 ET
|
TransUnion
Key findings from the TransUnion® report: Household financial strains most felt among Gen X (51%), as this generation nears retirement.Housing prices of concern to 57%, with only 14% intending to...
Interius BioTherapeutics Announces Regulatory Approval to Expand Phase 1 Clinical Trial of INT2104 into Europe
January 07, 2025 06:00 ET
|
Interius BioTherapeutics
German regulatory agency, the Paul Ehrlich Institute, granted approval to expand the INVISE Phase 1 clinical trial evaluating INT2104 for the treatment of B-cell malignancies to Europe The first...
Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights
January 07, 2025 06:00 ET
|
Verona Pharma plc
Approximately $36 million and $42 million net product sales of Ohtuvayre for the fourth quarter and full year 2024, respectively More than 3,500 unique prescribers and over 16,000 prescriptions...
WOLF INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Wolfspeed, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
January 07, 2025 05:59 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Wolfspeed, Inc. (NYSE: WOLF) securities between August 16, 2023 and...
Germany Building Integrated Photovoltaic (BIPV) Market Overview, Outlook and Forecast to 2030: Germany Pioneers Energy Transformation with Strong Growth in BIPV Market
January 07, 2025 05:58 ET
|
Research and Markets
Dublin, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The "Germany Building Integrated Photovoltaics Market | Revenue, Value, Forecast, Analysis, Size, Growth, Companies, Industry, Share & Trends: Market...
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
January 07, 2025 05:54 ET
|
Shore Capital Stockbrokers Limited
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) ...
- January 16, 2025 00:22 ET KFSH&RC Celebrates 25 Scientists Named in Stanford's Top 2% Most-Cited Researchers Worldwide
- January 15, 2025 21:43 ET EBC Financial Group in der Bewertung von FXEmpire für 2025 in vier Top-Kategorien ausgezeichnet